Welcome, GuestSign InSign Up
Position - / - - Profile

Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd

Business TypeManufacturer
Main MarketsNorth America South America Eastern Europe Southeast Asia Ea
Product/ServiceSucralose,Neotame,Moxifloxacin,Moxifloxacin Hcl,4-AA,4BMA,MAP,Meropenem
Business OwnerMr. Weize
Employees501 - 1000 People
RegionChina

Company Introduction

Shilang (Zhuoli Group)-Pharma (Nanjing) Co., Ltd. is a high-tech enterprise which is located in Nanjing, relying on the scientific research strength of China Pharmaceutical University, Nanjing University, and Nanjing University of Chemical Engineering Technology. We have independent ability of patent technology development, which makes us the backbone enterprise in Nanjing.

We belong to Shanxi Zhuoli Group. Our plant covers an area of more than 133,400 square meters. Our group has invested about 8 million US dollars in APIs and food additives. There are more than 300 employees, including 5 masters and 4 senior engineers. About 35% of 1ff8employees have bachelor or higher degrees and 52% have pharmaceutical knowledge. Our sales department is located in Nanjing comprised of 7 persons.

Our company specializes in the development, production and sale of pharmaceutical raw materials. We are at the leading level in both fermentation and chemical synthesis. Our products sell well in Europe, America, Southeast Asia, Africa and Oceania. We have established good business relationships with many customers.

Our principle is mutual benefit, so we try our best to manufacture high-tech products with high quality, and provide excellent service to meet customers' needs.

Contact Information

Contact PersonMs. BI XIAN
Telephone0086-25-85318152
Fax Number0086-25-85318910
Website
Post Code210009
AddressROOM 1601, A JINSHAN MANSION, 8 SHANXI ROAD, NANJING, NANJING, J
No advertising and no spamming please
Your Name
Your Rating
Comment
Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd no reviews currently
No reviews currently, you may post the first one.
About Us - Contact Us - Privacy Policy - Daily Updates - Report Abuse